- Home
- AUPH vs FUBO Comparison
AUPH vs FUBO Comparison
Compare AUPH & FUBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- FUBO
- Stock Information
- Founded
- AUPH 1993
- FUBO 2009
- Country
- AUPH Canada
- FUBO United States
- Employees
- AUPH N/A
- FUBO N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- FUBO Broadcasting
- Sector
- AUPH Health Care
- FUBO Industrials
- Exchange
- AUPH Nasdaq
- FUBO Nasdaq
- Market Cap
- AUPH 1.4B
- FUBO 1.5B
- IPO Year
- AUPH 1999
- FUBO 2020
- Fundamental
- Price
- AUPH $12.84
- FUBO $4.41
- Analyst Decision
- AUPH Strong Buy
- FUBO Buy
- Analyst Count
- AUPH 3
- FUBO 4
- Target Price
- AUPH $12.00
- FUBO $5.35
- AVG Volume (30 Days)
- AUPH 1.5M
- FUBO 13.1M
- Earning Date
- AUPH 11-06-2025
- FUBO 10-31-2025
- Dividend Yield
- AUPH N/A
- FUBO N/A
- EPS Growth
- AUPH N/A
- FUBO N/A
- EPS
- AUPH 0.42
- FUBO 0.26
- Revenue
- AUPH $260,111,000.00
- FUBO $1,625,738,000.00
- Revenue This Year
- AUPH $16.92
- FUBO N/A
- Revenue Next Year
- AUPH $14.43
- FUBO $6.48
- P/E Ratio
- AUPH $29.12
- FUBO $16.08
- Revenue Growth
- AUPH 25.59
- FUBO 6.65
- 52 Week Low
- AUPH $6.55
- FUBO $1.21
- 52 Week High
- AUPH $12.90
- FUBO $6.45
- Technical
- Relative Strength Index (RSI)
- AUPH 64.17
- FUBO 66.74
- Support Level
- AUPH $12.18
- FUBO $4.14
- Resistance Level
- AUPH $12.90
- FUBO $4.47
- Average True Range (ATR)
- AUPH 0.42
- FUBO 0.26
- MACD
- AUPH -0.06
- FUBO 0.06
- Stochastic Oscillator
- AUPH 95.11
- FUBO 89.55
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About FUBO fuboTV Inc.
FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.